Michael Cross
Clinical Instructor
Also affiliated: University of Vermont (2024); California Institute of Technology (2009); Practical Action (1983); Hospital for Special Surgery (2023); Dalhousie University (1977–2004); Rochester Institute of Technology (2024); Kenyon College (1970); Norwich University (2022–2025); University of Aberdeen (2019); Cornell University (2023); Barts Health NHS Trust (2003); University of Johannesburg (2015–2022); University of South Florida (1978); Raigmore Hospital (2019); University of Florida (2024); Education University of Hong Kong (2009); Central Arkansas Veterans Healthcare System (2025); Bellevue Hospital Center (2021); Queen Charlotte's and Chelsea Hospital (1992); Transnational Press London (2005–2011); University of the Highlands and Islands (2019); Carleton University (1966–1967); Tsinghua University (2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Michael Cross is a Clinical Instructor at the University of Arkansas for Medical Sciences. His research interests encompass several areas, including patient perceptions of pain management and opioid use in the context of hip arthroplasty, as well as the safety and efficacy of enoxaparin during percutaneous coronary intervention. Cross has also investigated the role of metabolic immaturity and breastmilk bile acid metabolites in newborn vulnerability to norovirus diarrhea. His work extends to exploring the integration of technology, such as iPads, into engineering classrooms and tackling real-world problems in first-year electrical engineering experiences. Cross has a publication record of 276 works, with 731 citations and an h-index of 12. He frequently collaborates with researchers at the University of Arkansas for Medical Sciences, including Malek Alaiwah, Omar Alqaisi, and Hani Alturkmani.
Metrics
- h-index: 12
- Publications: 276
- Citations: 738
Selected Publications
-
Successful Intravascular Lithotripsy Within a Covered Coronary Stent (2025)
-
Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)
-
100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
-
MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY (2023)
-
UTILIZING SHOCKWAVE THERAPY FOR THE TREATMENT OF RECURRENT INSTENT RESTENOSIS AND SIGNIFICANT CORONARY CALCIFICATION (2022)
Collaboration Network
Top Collaborators
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Successful Intravascular Lithotripsy Within a Covered Coronary Stent
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- UTILIZING SHOCKWAVE THERAPY FOR THE TREATMENT OF RECURRENT INSTENT RESTENOSIS AND SIGNIFICANT CORONARY CALCIFICATION
- MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- UTILIZING SHOCKWAVE THERAPY FOR THE TREATMENT OF RECURRENT INSTENT RESTENOSIS AND SIGNIFICANT CORONARY CALCIFICATION
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- UTILIZING SHOCKWAVE THERAPY FOR THE TREATMENT OF RECURRENT INSTENT RESTENOSIS AND SIGNIFICANT CORONARY CALCIFICATION
- MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY
- MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY
- MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY
- MULTIDISCIPLINARY, PATIENT-CENTERED APPROACH TO SEVERE, SYMPTOMATIC RHEUMATIC MITRAL STENOSIS IN PREGNANCY
Similar Researchers
Based on overlapping research topics